CP Reports
CP Insight
Current Agreements
CP Knowledge Centre
CP Consulting

New report

Provides comprehensive understanding and unprecedented access to the  clinical stage partnering agreements deals and agreements entered into by the worlds leading healthcare companies. More

 

Featured partnering deals

Manufacturing agreement for biologics between Bristol-Myers Squibb and Lonza

October 31, 2014 : Bristol-Myers Squibb, Lonza, manufacturing

Bristol-Myers Squibb Company and Lonza announced a multi-year expansion of their existing biologics manufacturing agreement. more »

Licensing agreement for ISPRI and Optimatrix platform for de-risking biologics

October 31, 2014 : Chugai, drug development

Chugai Pharmaceutical signed an agreement with EpiVax to incorporate EpiVax’s ISPRI immunogenicity screening and deimmunization technology into Chugai’s drug development toolbox. more »

 More partnering deals | all deals at Deal Monitor


Featured M&A deals

In m&a news: Optum has bought Alere Health for $600 million

October 30, 2014 : acquisition, biotech, M&A

In today’s m&a news, Optum buys Alere Health from Alere for $600 million.  more »

Abbott announces acquisition of Topera for $250 million

October 30, 2014 : Abbott, acquisition, M&A

Abbott has entered into an acquisition agreement to purchase Topera. more »

 More M&A deals | all deals at Deal Monitor

Featured financing deals

Chimerix sells $105 million worth stock in financing offering

October 31, 2014 : financing

Chimerix will be selling $105 million in stock as part of a $150 million shelf financing offering. more »

Blue Belt Technologies secures $40 million loan financing

October 31, 2014 : financing

Blue Belt Technologies and CR Group have closed a senior secured term loan financing for up to $40 million of capital. more »

 More financing deals | all deals at Deal Monitor

Latest Dealtalk

Bayer hungry for pharma deals to expand business

October 31, 2014 : Bayer, big pharma, dealtalk, pharma deals

Big pharma company Bayer , is going hunting for pharma deals again, with its chief executive expected to tell media outlets  that it is looking for further takeover pharma deals.  more »

Equity firms eye Bayer’s plastic business merger

October 27, 2014 : Bayer, big pharma, business merger

Private equity firms are circling Bayer’s €10bn plastics business merger, hoping to divert the German drugmaker from its plan to list the division, two people familiar with the matter said yesterday. more »

 More dealtalk

Featured reports

Global Joint Venture Partnerships

Publication date: October 2014

Top 50 Big Pharma Partnering and M&A

Publication date: October 2014

Bioinformatics Partnering Terms and Agreements

Publication date: October 2014

Top 50 Big Biotech Partnering and M&A

Publication date: October 2014

Molecular Diagnostics Partnering Terms and Agreements

Publication date: October 2014

Regenerative Medicine Partnering Terms and Agreements

Publication date: October 2014

Discovery Stage Partnering Terms and Agreements

Publication date: September 2014

Preclinical Stage Partnering Terms and Agreements

Publication date: September 2014

Co-development Terms and Agreements

Publication date: August 2014

Personalized Medicine in Oncology Partnering Terms and Agreements

Publication date: August 2014

Licensing Terms and Agreements

Publication date: August 2014

Diagnostic Imaging Partnering Terms and Agreements

Publication date: August 2014

Trends in Therapeutic Partnering

Publication date: August 2014

Cancer Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Monoclonal Antibody Terms and Agreements

Publication date: August 2014

Co-promotion & Co-marketing Partnering Terms and Agreements

Publication date: July 2014

Drug Delivery Terms and Agreements

Publication date: July 2014

NEW: Therapy deal reports covering all major indications

Including partnering in oncology, cardiovascular, CNS, metabolic, dermatology, dental, infectives, immunologypsychiatry, genitourinary.....plus many others

View all reports

Scorecard

Current Partnering provides access to key deal metrics for all leading partnering, M&A and financings - plus big pharma partnering activity and R&D spend metrics.

Available scorecards:

Partnering

M&A

Financing

Top 50 pharma partnering

Top 50 biotech partnering

Top pharma R&D spend

Deal metrics - by stage of development, therapy area, industry sector

Print Friendly
cpbannerad300x150new1gif
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new1gif
strategicalliances082114jpg
currentpartneringpharma-bio300x150gif